Testing nicotinamide riboside as a potential aid for long COVID recovery
Coronavirus
Mass General Brigham Nov 14 2025 Chao-Yi Wu, PhD, OT, from the Department of Neurology and Edmarie Guzmán-Vélez, PhD, of the Department of Psychiatry at Mass General Brigham, are the lead and senior authors of a paper published in eClinicalMedicine , "Effects of Nicotinamide Riboside on NAD+ Levels, Cognition, and Symptom Recovery in Long-COVID: A Randomized Controlled Trial." Q: How would you summarize your study for a lay audience? Millions of people worldwide continue to experience lingering
din zilele anterioare